These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10933399)

  • 1. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137.
    Lyons PA; Hancock WW; Denny P; Lord CJ; Hill NJ; Armitage N; Siegmund T; Todd JA; Phillips MS; Hess JF; Chen SL; Fischer PA; Peterson LB; Wicker LS
    Immunity; 2000 Jul; 13(1):107-15. PubMed ID: 10933399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.
    Irie J; Wu Y; Sass DA; Ridgway WM
    Immunogenetics; 2006 Feb; 58(1):9-14. PubMed ID: 16425035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
    Cannons JL; Chamberlain G; Howson J; Smink LJ; Todd JA; Peterson LB; Wicker LS; Watts TH
    J Autoimmun; 2005 Aug; 25(1):13-20. PubMed ID: 15998581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2.
    Siegmund T; Armitage N; Wicker LS; Peterson LB; Todd JA; Lyons PA
    Diabetes; 2000 Sep; 49(9):1612-6. PubMed ID: 10969850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.
    Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM
    J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice.
    Lin B; Ciecko AE; MacKinney E; Serreze DV; Chen YG
    Immunogenetics; 2017 Mar; 69(3):193-198. PubMed ID: 27796442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus.
    Forsberg MH; Foda B; Serreze DV; Chen YG
    Sci Rep; 2019 Mar; 9(1):4316. PubMed ID: 30867509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection.
    Berry GJ; Budgeon LR; Cooper TK; Christensen ND; Waldner H
    Eur J Immunol; 2014 Jun; 44(6):1716-27. PubMed ID: 24752729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
    Yamanouchi J; Puertas MC; Verdaguer J; Lyons PA; Rainbow DB; Chamberlain G; Hunter KM; Peterson LB; Wicker LS; Santamaria P
    Diabetes; 2010 Jan; 59(1):272-81. PubMed ID: 19833887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
    Pakala SV; Chivetta M; Kelly CB; Katz JD
    J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide transcriptional analyses of islet-specific CD4+ T cells identify Idd9 genes controlling diabetogenic T cell function.
    Berry GJ; Frielle C; Luu T; Salzberg AC; Rainbow DB; Wicker LS; Waldner H
    J Immunol; 2015 Mar; 194(6):2654-63. PubMed ID: 25672752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.
    Walter U; Franzke A; Sarukhan A; Zober C; von Boehmer H; Buer J; Lechner O
    Eur J Immunol; 2000 Apr; 30(4):1224-32. PubMed ID: 10760812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.
    Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS
    Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans.
    Hill NJ; Lyons PA; Armitage N; Todd JA; Wicker LS; Peterson LB
    Diabetes; 2000 Oct; 49(10):1744-7. PubMed ID: 11016460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.
    Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y
    J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autoimmune diabetes locus Idd9 regulates development of type 1 diabetes by affecting the homing of islet-specific T cells.
    Waldner H; Sobel RA; Price N; Kuchroo VK
    J Immunol; 2006 May; 176(9):5455-62. PubMed ID: 16622013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice.
    Kachapati K; Bednar KJ; Adams DE; Wu Y; Mittler RS; Jordan MB; Hinerman JM; Herr AB; Ridgway WM
    J Autoimmun; 2013 Dec; 47():94-103. PubMed ID: 24145149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of type 1 diabetes regions Idd9.1 and Idd9.2 reveals genetic complexity.
    Hamilton-Williams EE; Rainbow DB; Cheung J; Christensen M; Lyons PA; Peterson LB; Steward CA; Sherman LA; Wicker LS
    Mamm Genome; 2013 Oct; 24(9-10):358-75. PubMed ID: 23934554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis.
    Mayo S; Kohler W; Kumar V; Quinn A
    Clin Immunol; 2006; 118(2-3):219-28. PubMed ID: 16301001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
    Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
    J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.